Cutler Group LP Heron Therapeutics, Inc. Transaction History

Cutler Group LP

$307 Million
Q1 2024

A detailed history of Cutler Group LP transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Cutler Group LP holds 2,800 shares of HRTX stock, worth $3,080. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,800

Previous 2,900 3.45%

Holding current value

$3,080

Previous $4,000 75.0%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$1.71 - $3.06 $171 - $306	-100 Reduced 3.45%	2,800 $7,000
Q3 2022 Oct 25, 2022	SELL	$2.66 - $5.37 $1,159 - $2,341	-436 Reduced 13.07%	2,900 $12,000
Q2 2022 Aug 04, 2022	SELL	$2.3 - $6.29 $3,679 - $10,064	-1,600 Reduced 32.41%	3,336 $9,000
Q1 2022 Apr 14, 2022	BUY	$4.63 - $9.94 $9,426 - $20,237	2,036 Added 70.21%	4,936 $28,000
Q2 2021 Jul 19, 2021	BUY	$13.27 - $18.48 $14,597 - $20,328	1,100 Added 61.11%	2,900 $45,000

Q1 2021 Apr 26, 2021	BUY	$14.49 - $20.72 $24,633 - $35,224	1,700 Added 1700.0%	1,800 $29,000
Q4 2020 Jan 21, 2021	SELL	$14.61 - $22.14 $104,446 - $158,278	-7,149 Reduced 98.62%	100 $2,000
Q3 2020 Oct 27, 2020	BUY	$13.67 - $17.77 $37,578 - $48,849	2,749 Added 61.09%	7,249 $107,000
Q2 2020 Jul 22, 2020	SELL	$10.89 - $21.47 $31,581 - $62,263	-2,900 Reduced 39.19%	4,500 $66,000
Q1 2020 May 07, 2020	BUY	$10.23 - $24.56 $75,702 - $181,744	7,400 New	7,400 $86,000
Q4 2019 Feb 06, 2020	SELL	$17.42 - $26.61 $78,390 - $119,745	-4,500 Closed	0 $0
Q3 2019 Oct 28, 2019	BUY	$16.36 - $21.39 $26,176 - $34,224	1,600 Added 55.17%	4,500 $83,000
Q2 2019 Aug 09, 2019	BUY	$16.93 - $26.22 $38,939 - $60,306	2,300 Added 383.33%	2,900 $53,000
Q1 2019 May 10, 2019	SELL	$23.15 - $28.34 $2,315 - $2,834	-100 Reduced 14.29%	600 $14,000
Q4 2018 Feb 05, 2019	SELL	$22.03 - $32.01 $6,609 - $9,603	-300 Reduced 30.0%	700 $18,000
Q3 2018 Nov 07, 2018	BUY	$30.0 - $40.85 $21,000 - $28,595	700 Added 233.33%	1,000 $31,000
Q2 2018 Aug 10, 2018	SELL	$26.4 - $42.0 $291,535 - $463,806	-11,043 Reduced 97.36%	300 $11,000
Q1 2018 May 11, 2018	BUY	$18.43 - $28.8 $138,722 - $216,777	7,527 Added 197.25%	11,343 $313,000
Q3 2017 Oct 17, 2017	BUY	$14.65 - $16.85 $55,904 - $64,299	3,816	3,816 $61,000

Others Institutions Holding HRTX

# of Institutions

189

Shares Held

151M

Call Options Held

20.1K

Put Options Held

2.12M

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $131M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account